202 related articles for article (PubMed ID: 32402085)
1. Deletion of fibroblast activation protein provides atheroprotection.
Stein S; Weber J; Nusser-Stein S; Pahla J; Zhang HE; Mohammed SA; Oppi S; Gaul DS; Paneni F; Tailleux A; Staels B; von Meyenn F; Ruschitzka F; Gorrell MD; Lüscher TF; Matter CM
Cardiovasc Res; 2021 Mar; 117(4):1060-1069. PubMed ID: 32402085
[TBL] [Abstract][Full Text] [Related]
2. Attenuated Superoxide Dismutase 2 Activity Induces Atherosclerotic Plaque Instability During Aging in Hyperlipidemic Mice.
Vendrov AE; Stevenson MD; Alahari S; Pan H; Wickline SA; Madamanchi NR; Runge MS
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079564
[TBL] [Abstract][Full Text] [Related]
3. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
[TBL] [Abstract][Full Text] [Related]
4. Membrane-Tethered Metalloproteinase Expressed by Vascular Smooth Muscle Cells Limits the Progression of Proliferative Atherosclerotic Lesions.
Barnes RH; Akama T; Öhman MK; Woo MS; Bahr J; Weiss SJ; Eitzman DT; Chun TH
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735290
[TBL] [Abstract][Full Text] [Related]
5. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
6. Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.
Gray SP; Di Marco E; Kennedy K; Chew P; Okabe J; El-Osta A; Calkin AC; Biessen EA; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):295-307. PubMed ID: 26715682
[TBL] [Abstract][Full Text] [Related]
7. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
9. Ablation of Myeloid ADK (Adenosine Kinase) Epigenetically Suppresses Atherosclerosis in ApoE
Zhang M; Zeng X; Yang Q; Xu J; Liu Z; Zhou Y; Cao Y; Zhang X; An X; Xu Y; Huang L; Han Z; Wang T; Wu C; Fulton DJ; Weintraub NL; Hong M; Huo Y
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2780-2792. PubMed ID: 30571174
[TBL] [Abstract][Full Text] [Related]
10. SHP2 inhibitor PHPS1 protects against atherosclerosis by inhibiting smooth muscle cell proliferation.
Chen J; Cao Z; Guan J
BMC Cardiovasc Disord; 2018 Apr; 18(1):72. PubMed ID: 29703160
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling.
Schwanekamp JA; Lorts A; Vagnozzi RJ; Vanhoutte D; Molkentin JD
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):60-8. PubMed ID: 26564821
[TBL] [Abstract][Full Text] [Related]
12. TSP-1 (Thrombospondin-1) Deficiency Protects ApoE
Ganguly R; Khanal S; Mathias A; Gupta S; Lallo J; Sahu S; Ohanyan V; Patel A; Storm K; Datta S; Raman P
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):e112-e127. PubMed ID: 33327743
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21 deficiency attenuated atherogenesis and decreased macrophage infiltration by targeting Dusp-8.
Gao L; Zeng H; Zhang T; Mao C; Wang Y; Han Z; Chen K; Zhang J; Fan Y; Gu J; Wang C
Atherosclerosis; 2019 Dec; 291():78-86. PubMed ID: 31704554
[TBL] [Abstract][Full Text] [Related]
14. SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.
Sukhanov S; Higashi Y; Shai SY; Snarski P; Danchuk S; D'Ambra V; Tabony M; Woods TC; Hou X; Li Z; Ozoe A; Chandrasekar B; Takahashi SI; Delafontaine P
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2306-2317. PubMed ID: 30354209
[TBL] [Abstract][Full Text] [Related]
15. Adam17 Deficiency Promotes Atherosclerosis by Enhanced TNFR2 Signaling in Mice.
Nicolaou A; Zhao Z; Northoff BH; Sass K; Herbst A; Kohlmaier A; Chalaris A; Wolfrum C; Weber C; Steffens S; Rose-John S; Teupser D; Holdt LM
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):247-257. PubMed ID: 28062509
[TBL] [Abstract][Full Text] [Related]
16. Fibronectin extra domain A stabilises atherosclerotic plaques in apolipoprotein E and in LDL-receptor-deficient mice.
Pulakazhi Venu VK; Uboldi P; Dhyani A; Patrini A; Baetta R; Ferri N; Corsini A; Muro AF; Catapano AL; Norata GD
Thromb Haemost; 2015 Jul; 114(1):186-97. PubMed ID: 25881051
[TBL] [Abstract][Full Text] [Related]
17. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting Integrin α5 Cytoplasmic Domain Signaling Reduces Atherosclerosis and Promotes Arteriogenesis.
Budatha M; Zhang J; Zhuang ZW; Yun S; Dahlman JE; Anderson DG; Schwartz MA
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29382667
[TBL] [Abstract][Full Text] [Related]
19. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses.
Herías V; Biessen EA; Beckers C; Delsing D; Liao M; Daemen MJ; Pham CC; Heeneman S
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):79-86. PubMed ID: 25395616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]